It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Perinatal traits are influenced by fetal and maternal genomes. We investigate the performance of three strategies to detect loci in maternal and fetal genome-wide association studies (GWASs) of the same quantitative trait: (i) the traditional strategy of analysing maternal and fetal GWASs separately; (ii) a two-degree-of-freedom test which combines information from maternal and fetal GWASs; and (iii) a one-degree-of-freedom test where signals from maternal and fetal GWASs are meta-analysed together conditional on estimated sample overlap. We demonstrate that the optimal strategy depends on the extent of sample overlap, correlation between phenotypes, whether loci exhibit fetal and/or maternal effects, and whether these effects are directionally concordant. We apply our methods to summary statistics from a recent GWAS meta-analysis of birth weight. Both the two-degree-of-freedom and meta-analytic approaches increase the number of genetic loci for birth weight relative to separately analysing the scans. Our best strategy identifies an additional 62 loci compared to the most recently published meta-analysis of birth weight. We conclude that whilst the two-degree-of-freedom test may be useful for the analysis of certain perinatal phenotypes, for most phenotypes, a simple meta-analytic strategy is likely to perform best, particularly in situations where maternal and fetal GWASs only partially overlap.
Perinatal traits such as birth weight are influenced partly by indirect maternal genetic effects, i.e. mediated through the intrauterine environment. Here the authors present a method to increase the power of locus discovery in genome-wide association studies of these traits.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Cuellar-Partida, Gabriel 2 ; Yengo, Loic 1
; Zeng, Jian 1 ; Toivonen, Jarkko 3
; Arvas, Mikko 3
; Beaumont, Robin N. 4
; Freathy, Rachel M. 5
; Moen, Gunn-Helen 6 ; Warrington, Nicole M. 7
; Evans, David M. 8
1 The University of Queensland, Institute for Molecular Bioscience, St Lucia, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537)
2 Inc, Gilead Sciences, Foster City, USA (GRID:grid.437263.7)
3 Finnish Red Cross Blood Service, Vantaa, Finland (GRID:grid.452433.7) (ISNI:0000 0000 9387 9501)
4 University of Exeter, Department of Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, Exeter, UK (GRID:grid.8391.3) (ISNI:0000 0004 1936 8024)
5 University of Exeter, Department of Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, Exeter, UK (GRID:grid.8391.3) (ISNI:0000 0004 1936 8024); University of Bristol, MRC Integrative Epidemiology Unit, Bristol, UK (GRID:grid.5337.2) (ISNI:0000 0004 1936 7603)
6 The University of Queensland, Institute for Molecular Bioscience, St Lucia, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537); University of Oslo, Institute of Clinical Medicine, Faculty of Medicine, Oslo, Norway (GRID:grid.5510.1) (ISNI:0000 0004 1936 8921); Norwegian University of Science and Technology, Department of Public Health and Nursing, K.G. Jebsen Center for Genetic Epidemiology, NTNU, Trondheim, Norway (GRID:grid.5947.f) (ISNI:0000 0001 1516 2393); The University of Queensland, The Frazer Institute, Woolloongabba, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537)
7 The University of Queensland, Institute for Molecular Bioscience, St Lucia, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537); University of Bristol, MRC Integrative Epidemiology Unit, Bristol, UK (GRID:grid.5337.2) (ISNI:0000 0004 1936 7603); Norwegian University of Science and Technology, Department of Public Health and Nursing, K.G. Jebsen Center for Genetic Epidemiology, NTNU, Trondheim, Norway (GRID:grid.5947.f) (ISNI:0000 0001 1516 2393); The University of Queensland, The Frazer Institute, Woolloongabba, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537)
8 The University of Queensland, Institute for Molecular Bioscience, St Lucia, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537); University of Bristol, MRC Integrative Epidemiology Unit, Bristol, UK (GRID:grid.5337.2) (ISNI:0000 0004 1936 7603); The University of Queensland, The Frazer Institute, Woolloongabba, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537)




